Multicenter Comparative Multimodality Surveillance of Women at Genetic-Familial High Risk for Breast Cancer (HIBCRIT Study): Interim Results1 F Sardanelli, F Podo, G D'Agnolo, A Verdecchia, M Santaquilani, ... Radiology 242 (3), 698-715, 2007 | 436 | 2007 |
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally … D Miles, J Gligorov, F André, D Cameron, A Schneeweiss, C Barrios, B Xu, ... Annals of Oncology 32 (8), 994-1004, 2021 | 419 | 2021 |
Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast … F Sardanelli, F Podo, F Santoro, S Manoukian, S Bergonzi, G Trecate, ... Investigative radiology 46 (2), 94-105, 2011 | 374 | 2011 |
Hereditary ovarian cancer: not only BRCA 1 and 2 genes A Toss, C Tomasello, E Razzaboni, G Contu, G Grandi, A Cagnacci, ... BioMed research international 2015, 2015 | 297 | 2015 |
An overview of PARP inhibitors for the treatment of breast cancer L Cortesi, HS Rugo, C Jackisch Targeted oncology 16 (3), 255-282, 2021 | 228 | 2021 |
The Italian multi-center project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk F Podo, F Sardanelli, R Canese, G D'Agnolo, PG Natali, M Crecco, ... Journal of Experimental & Clinical Cancer Research 21, 115-124, 2002 | 207 | 2002 |
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores J Lecarpentier, V Silvestri, KB Kuchenbaecker, D Barrowdale, J Dennis, ... Journal of Clinical Oncology 35 (20), 2240, 2017 | 191 | 2017 |
Randomized placebo controlled trial of low-dose tamoxifen to prevent local and contralateral recurrence in breast intraepithelial neoplasia A DeCensi, M Puntoni, A Guerrieri-Gonzaga, S Caviglia, F Avino, ... Journal of Clinical Oncology 37 (19), 1629, 2019 | 171 | 2019 |
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer CE Geyer Jr, JE Garber, RD Gelber, G Yothers, M Taboada, L Ross, ... Annals of oncology 33 (12), 1250-1268, 2022 | 155 | 2022 |
Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2 V Silvestri, D Barrowdale, AM Mulligan, SL Neuhausen, S Fox, BY Karlan, ... Breast Cancer Research 18, 1-13, 2016 | 144 | 2016 |
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification MT Parsons, E Tudini, H Li, E Hahnen, B Wappenschmidt, L Feliubadaló, ... Human mutation 40 (9), 1557-1578, 2019 | 120 | 2019 |
Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in Italy L Ottini, V Silvestri, P Rizzolo, M Falchetti, I Zanna, C Saieva, G Masala, ... Breast cancer research and treatment 134, 411-418, 2012 | 110 | 2012 |
FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor P Peterlongo, I Catucci, M Colombo, L Caleca, E Mucaki, M Bogliolo, ... Human molecular genetics 24 (18), 5345-5355, 2015 | 104 | 2015 |
Prevalence, incidence and mortality of diagnosed diabetes: evidence from an Italian population‐based study L Monesi, M Baviera, I Marzona, F Avanzini, G Monesi, A Nobili, ... Diabetic medicine 29 (3), 385-392, 2012 | 98 | 2012 |
The association between endometriomas and ovarian cancer: preventive effect of inhibiting ovulation and menstruation during reproductive life G Grandi, A Toss, L Cortesi, L Botticelli, A Volpe, A Cagnacci BioMed research international 2015, 2015 | 94 | 2015 |
Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era A Toss, C Isca, M Venturelli, C Nasso, G Ficarra, V Bellelli, C Armocida, ... ESMO open 6 (2), 100055, 2021 | 89 | 2021 |
Pregnancy After Breast Cancer in Patients With Germline BRCA Mutations M Lambertini, L Ameye, AS Hamy, A Zingarello, PD Poorvu, E Carrasco, ... Journal of Clinical Oncology 38 (26), 3012-3023, 2020 | 82 | 2020 |
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients MV Lenti, L Pasina, S Cococcia, L Cortesi, E Miceli, CC Dominioni, ... European Journal of Internal Medicine 61, 54-61, 2019 | 80 | 2019 |
Breast cancer screening in women at increased risk according to different family histories: an update of the Modena Study Group experience L Cortesi, D Turchetti, I Marchi, A Fracca, B Canossi, R Battista, S Ruscelli, ... BMC cancer 6, 1-9, 2006 | 74 | 2006 |
Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going C Omarini, G Guaitoli, S Pipitone, L Moscetti, L Cortesi, S Cascinu, ... Cancer management and research, 91-103, 2018 | 72 | 2018 |